These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 10024542

  • 21. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses.
    Cherry JD, Gornbein J, Heininger U, Stehr K.
    Vaccine; 1998 Dec; 16(20):1901-6. PubMed ID: 9796041
    [Abstract] [Full Text] [Related]

  • 22. Protective activities in mice of monoclonal antibodies against pertussis toxin.
    Sato H, Sato Y.
    Infect Immun; 1990 Oct; 58(10):3369-74. PubMed ID: 1698179
    [Abstract] [Full Text] [Related]

  • 23. The filamentous hemagglutinin of Bordetella parapertussis is the major adhesin in the phase-dependent interaction with NCI-H292 human lung epithelial cells.
    van den Akker WM.
    Biochem Biophys Res Commun; 1998 Nov 09; 252(1):128-33. PubMed ID: 9813157
    [Abstract] [Full Text] [Related]

  • 24. Molecular aspects of Bordetella pertussis pathogenesis.
    Locht C.
    Int Microbiol; 1999 Sep 09; 2(3):137-44. PubMed ID: 10943406
    [Abstract] [Full Text] [Related]

  • 25. Dissecting human T cell responses against Bordetella species.
    De Magistris MT, Romano M, Nuti S, Rappuoli R, Tagliabue A.
    J Exp Med; 1988 Oct 01; 168(4):1351-62. PubMed ID: 2902185
    [Abstract] [Full Text] [Related]

  • 26. Virus-like particles displaying the mature C-terminal domain of filamentous hemagglutinin are immunogenic and protective against Bordetella pertussis respiratory infection in mice.
    Pyles GM, Huckaby AB, Gutierrez MdlP, Witt WT, Mateu-Borrás M, Dublin SR, Rocuskie-Marker C, Sesti BN, Peasak K, Bitzer GJ, Rader N, Weaver KL, Boehm DT, Fitzgerald N, Chapman J, Ulicny S, Damron FH, Barbier M.
    Infect Immun; 2024 Aug 13; 92(8):e0027024. PubMed ID: 39023271
    [Abstract] [Full Text] [Related]

  • 27. Cooperative roles for fimbria and filamentous hemagglutinin in Bordetella adherence and immune modulation.
    Scheller EV, Melvin JA, Sheets AJ, Cotter PA.
    mBio; 2015 May 26; 6(3):e00500-15. PubMed ID: 26015497
    [Abstract] [Full Text] [Related]

  • 28. Immunogenicity of an acellular pertussis vaccine composed of genetically inactivated pertussis toxin combined with filamentous hemagglutinin and pertactin in infants and children.
    Podda A, Carapella De Luca E, Titone L, Casadei AM, Cascio A, Bartalini M, Volpini G, Peppoloni S, Marsili I, Nencioni L.
    J Pediatr; 1993 Jul 26; 123(1):81-4. PubMed ID: 8320630
    [Abstract] [Full Text] [Related]

  • 29. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens.
    Macdonald-Fyall J, Xing D, Corbel M, Baillie S, Parton R, Coote J.
    Vaccine; 2004 Oct 22; 22(31-32):4270-81. PubMed ID: 15474718
    [Abstract] [Full Text] [Related]

  • 30. Identification of a carbohydrate recognition domain in filamentous hemagglutinin from Bordetella pertussis.
    Prasad SM, Yin Y, Rodzinski E, Tuomanen EI, Masure HR.
    Infect Immun; 1993 Jul 22; 61(7):2780-5. PubMed ID: 8514379
    [Abstract] [Full Text] [Related]

  • 31. Response and decline of serum IgG antibodies to pertussis toxin, filamentous hemagglutinin and pertactin in children with pertussis.
    Isacson J, Trollfors B, Hedvall G, Taranger J, Zackrisson G.
    Scand J Infect Dis; 1995 Jul 22; 27(3):273-7. PubMed ID: 8539553
    [Abstract] [Full Text] [Related]

  • 32. Protection and humoral immune responses against Bordetella pertussis infection in mice immunized with acellular or cellular pertussis immunogens.
    van den Berg BM, David S, Beekhuizen H, Mooi FR, van Furth R.
    Vaccine; 2000 Dec 08; 19(9-10):1118-28. PubMed ID: 11137247
    [Abstract] [Full Text] [Related]

  • 33. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis.
    Storsaeter J, Hallander HO, Gustafsson L, Olin P.
    Vaccine; 1998 Dec 08; 16(20):1907-16. PubMed ID: 9796042
    [Abstract] [Full Text] [Related]

  • 34. Investigation of the Cellular Immune Response to Recombinant Fragments of Filamentous Hemagglutinin and Pertactin of Bordetella pertussis in BALB/c Mice.
    Bakhshaei P, Kazemi MH, Golara M, Abdolmaleki S, Khosravi-Eghbal R, Khoshnoodi J, Judaki MA, Salimi V, Douraghi M, Jeddi-Tehrani M, Shokri F.
    J Interferon Cytokine Res; 2018 Apr 08; 38(4):161-170. PubMed ID: 29638208
    [Abstract] [Full Text] [Related]

  • 35. Interaction of Bordetella pertussis filamentous hemagglutinin with human TLR2: identification of the TLR2-binding domain.
    Asgarian-Omran H, Amirzargar AA, Zeerleder S, Mahdavi M, van Mierlo G, Solati S, Jeddi-Tehrani M, Rabbani H, Aarden L, Shokri F.
    APMIS; 2015 Feb 08; 123(2):156-62. PubMed ID: 25353353
    [Abstract] [Full Text] [Related]

  • 36. Pertactin-Negative and Filamentous Hemagglutinin-Negative Bordetella pertussis, Australia, 2013-2017.
    Xu Z, Octavia S, Luu LDW, Payne M, Timms V, Tay CY, Keil AD, Sintchenko V, Guiso N, Lan R.
    Emerg Infect Dis; 2019 Jun 08; 25(6):1196-1199. PubMed ID: 31107218
    [Abstract] [Full Text] [Related]

  • 37. Efficacy of chemically cross-linked antigens for acellular pertussis vaccine.
    Watanabe M, Nagai M, Funaishi K, Endoh M.
    Vaccine; 2000 Dec 08; 19(9-10):1199-203. PubMed ID: 11137257
    [Abstract] [Full Text] [Related]

  • 38. Role of pertussigen (pertussis toxin) on the mouse protective activity of vaccines made from Bordetella species.
    Munoz JJ, Peacock MG.
    Microbiol Immunol; 1989 Dec 08; 33(4):341-55. PubMed ID: 2549344
    [Abstract] [Full Text] [Related]

  • 39. Phase I clinical trial of an acellular pertussis vaccine composed of genetically detoxified pertussis toxin combined with FHA and 69 kDa.
    Podda A, Nencioni L, Marsili I, Peppoloni S, Volpini G, Donati D, Di Tommaso A, De Magistris MT, Rappuoli R.
    Vaccine; 1991 Oct 08; 9(10):741-5. PubMed ID: 1759492
    [Abstract] [Full Text] [Related]

  • 40. Antibodies produced against a fragment of filamentous haemagglutinin (FHA) of Bordetella pertussis are able to inhibit hemagglutination induced by the whole adhesin.
    Colombi D, Horton DS, Oliveira ML, Sakauchi MA, Ho PL.
    FEMS Microbiol Lett; 2004 Nov 01; 240(1):41-7. PubMed ID: 15500977
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.